ArticleNature communications2024

A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice.

Aman Mebrahtu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.